DIABETES INJECTION PENS MARKET ANALYSIS
Rising incidence of diabetes is expected to propel the demand for insulin injection pens
Rising incidence diabetes is one of the major factors responsible for growth of the global diabetes injection pens market. According to the American Diabetes Association, around 30.3 million of people in the U.S. suffered from diabetes, accounting for up to 9.4% of the total population in 2016. Moreover, according to the BMJ Open Diabetes Research & Care, around 387 million people in the world suffer from diabetes, out of which around 5-10% suffer from type-1 diabetes. Various other factors driving growth of the market include risk of needle-stick injuries and bacterial infection caused by regular use of syringes to inject insulin and the advancements technology related to diabetes pens, leading to development of painless devices for daily insulin injections. However, the availability of insulin patches and other substitutes for insulin delivery are expected to hamper the growth of the market.
Market Taxonomy:
On the basis of product type, the global diabetes injection pen market is segmented into:
On the basis of usage, the global diabetes injection pens market is segmented into:
On the basis of distribution channel, the global diabetes injection pens market is segmented into:
Market- Trends
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
